You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
13 July 2022
Resaphene Suisse AG: FDA approval process for tinnitus therapy tinniwell continues (news with additional features)
18 May 2020
Resaphene Suisse AG: Tinnitus: 4 phases until healing in the Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell
31 March 2020
Resaphene Suisse AG: Correction of the ad hoc announcement dated March 30, 2020 Resaphene Suisse AG has announced the withdrawal of inclusion in the Vienna MTF at the Vienna Stock Exchange
30 March 2020
Resaphene Suisse AG: Resaphene Suisse AG has applied for delisting at the Vienna Stock Exchange
21 January 2020
Resaphene Suisse AG: Charité Ethics Committee in Berlin approves study on tinniwell tinnitus therapy
4 September 2019
Resaphene Suisse AG: Erfolgreicher Einsatz von Wärmetherapie bei Schlafstörungen in der Tinnitus-Therapie (News mit Zusatzmaterial)